Diagnostic work-up and outcome of cervical metastases from an unknown primary

被引:42
作者
Guntinas-Lichius, O [1 ]
Klussmann, JP
Dinh, S
Dinh, M
Schmidt, M
Semrau, R
Mueller, RP
机构
[1] Univ Cologne, Clin Otorhinolaryngol Head & Neck Surg, Dept Otorhinolaryngol, D-50924 Cologne, Germany
[2] Univ Cologne, Dept Nucl Med, D-50924 Cologne, Germany
[3] Univ Cologne, Dept Radiotherapy, D-50924 Cologne, Germany
关键词
head and neck cancer; carcinoma of unknown primary; positron emission tomography; neck dissection; radiotherapy; chemotherapy;
D O I
10.1080/00016480500417304
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Conclusions. An intensive diagnostic work-up including F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) detects many unknown primary tumours, leads to a low emergence rate of primary tumours, and selects carcinoma of unknown primary with much more favourable results after neck dissection and postoperative radiotherapy. Objective. To investigate the optimal diagnostic approach and best treatment modality for rare head and neck cancer of unknown primary. Patients and methods. In a retrospective study, 69 patients admitted from 1987 to 2002 with cervical lymph node metastases without apparent primary were reviewed. Test characteristics of all diagnostic procedures were calculated. Disease-free and overall survival rates were calculated. Major prognostic factors were analysed univariately. Results. At the primary site FDG-PET showed the best sensitivity with 69% and the highest negative predictive value with 87%. Computed tomography and magnetic resonance imaging had a better specificity with 87% and 95%, respectively. The primary tumour was detected in 23 cases (33%). Frequent primary tumour origin was the palatine tonsil ( n = 8, 35%), base of the tongue ( n = 6, 26%) and lung ( n = 4, 17%). All patients with unknown primary were treated by neck dissection. Adjuvant radiotherapy was performed in 26 patients (57%), concurrent radiochemotherapy was performed in 12 patients ( 26%). The primary emergence rate was 7%. The 5-year overall survival rate was inferior in patients with detected primary in comparison with patients with unknown primary (22% versus 52%). Significant prognostic factors in case of unknown primary were M stage, smoking, alcohol consumption and tonsillectomy. Radiotherapy but not chemotherapy with carboplatin influenced the overall survival.
引用
收藏
页码:536 / 544
页数:9
相关论文
共 28 条
[1]  
Adams Jeff R, 2002, Asian J Surg, V25, P188, DOI 10.1016/S1015-9584(09)60172-X
[2]  
ALTMAN E, 1986, CANCER-AM CANCER SOC, V57, P120, DOI 10.1002/1097-0142(19860101)57:1<120::AID-CNCR2820570124>3.0.CO
[3]  
2-M
[4]  
[Anonymous], 2002, TNM CLASSIFICATION M
[5]   Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary [J].
Argiris, A ;
Smith, SM ;
Stenson, K ;
Mittal, BB ;
Pelzer, HJ ;
Kies, MS ;
Haraf, DJ ;
Vokes, EE .
ANNALS OF ONCOLOGY, 2003, 14 (08) :1306-1311
[6]   Management of unknown primary tumor [J].
Chepeha, D ;
Koch, W ;
Pitman, K .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (06) :499-504
[7]   METASTASES TO LYMPH-NODES OF HEAD AND NECK FROM AN UNKNOWN PRIMARY SITE [J].
COKER, DD ;
CASTERLINE, PF ;
CHAMBERS, RG ;
JAQUES, DA .
AMERICAN JOURNAL OF SURGERY, 1977, 134 (04) :517-522
[8]   Cervical lymph node metastases from unknown primary tumours - Results from a national survey by the Danish Society for Head and Neck Oncology [J].
Grau, C ;
Johansen, LV ;
Jakobsen, J ;
Geertsen, P ;
Andersen, E ;
Jensen, BB .
RADIOTHERAPY AND ONCOLOGY, 2000, 55 (02) :121-129
[9]   Diagnostic strategies in cervical carcinoma of an unknown primary (CUP) [J].
Haas, I ;
Hoffmann, TK ;
Engers, R ;
Ganzer, U .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2002, 259 (06) :325-333
[10]  
HAINSWORTH JD, 1993, NEW ENGL J MED, V329, P257